Healthcare-associated infections (HAI) are an important public health threat with the 20 multidrug-resistant (MDR) gram-negative bacteria (GNB) being of particular concern. Here 21 we present the antimicrobial resistance profile of HAI-related GNB (HAIrB) isolated from 22 patients (PT), healthcare workers (HCW) and hospital environment (HE) in a six-month 23 screening program. From the 180 sampling points distributed in six hospital units, a total of 24 1,080 swabs were collected allowing the isolation of 390 HAIrB: 50.5% from HE, 42.6% 25 2 from PT and 6.9% from HCW. Among the HAIrB, 32.6% were characterized as MDR and 26 38.7% as extended-spectrum cephalosporins resistant (ESC-R), showing no differences in the 27 distribution between PT, HE and HCW. Carbapenem resistance (CARB-R) was detected for 28 17.7% of all HAIrB, being higher among Acinetobacter spp. isolates (36.5%), followed by 29 Enterobacteriaceae (14.5%) and Pseudomonas spp. (11.8%). Except for the ICU, that 30 revealed higher MDR, CARB-R and ESC-R rates, HAIrB-resistant profiles were similarly 31 detected within the hospital units. Prevalence of bla KPC-like and bla CTX-M-1 β-lactamases-32 resistance genes was higher in K. pneumoniae and E. cloacae complex, while bla OXA-23-like 33 and bla SPM-like were higher in A. baumannii and P. aeruginosa, respectively. This study 34 reveals that the spreading of HAIrB within a hospital environment is higher than predicted, 35
Introduction 40
Healthcare-associated infections (HAI) are important public health threats requiring 41 continuous monitoring and efficient surveillance programs (1) . HAI caused by multidrug-42 resistant (MDR) gram-negative bacteria (GNB) are of particular concern, with high-risk 43 global alerts (2-4). HAI can seriously affect patient health, promoting long-term hospital 44 stays and increasing the mortality, in addition to impose high costs for the healthcare system 45 (5-7). There are many evidences that the hospital environment and the healthcare workers are 46 key players on large-scale dissemination of MDR bacteria (8-11). Also, the combination of 47 fast human mobility around the world with selective pressure by overuse and misuse of 48 antibiotics in human and food-producing animals along with the difficulties in adopting 49 simple control measures, form the perfect system to ensure the spread of MDR bacteria (12-50 4 Collected swabs were inoculated in Brain Heart Infusion (BHI) broth (BD, USA), incubated 76 for 12-18 hours at 36 °C (±1 °C) prior to plating on selective MacConkey agar (BD, USA), 77 following incubation (18-24 hours) at 36 °C (±1 °C). Different morphotypes of Forming Units (CFU) were isolated and transferred onto new MacConkey agar plates. 79
Identification and antimicrobial susceptibility test (AST) of each isolate were performed 80 using Vitek ® 2 (BioMérieux Inc., USA) GN ID and AST-N239 cards according to the 81 manufacturer's instructions. Based on the AST results, the isolates were then classified as 82 "not multidrug-resistant" (Not MDR) or "multidrug-resistant" (MDR), according to the 83 acquired resistance classification (17). 84
Genotypic analyses 85
DNA from all GNB isolates was obtained using a magnetic beads protocol (Neoprospecta 86 Microbiome Technologies, Brazil) and quantified using Qubit dsDNA BR Assay Kit 87 (Invitrogen, USA). A panel of the most important β-lactamases genes in the Brazilian 88 scenario (Table S2 ) was tested by qPCR using specific primers and hydrolysis probes in a 89 duplex or triplex configuration. The qPCR reactions were carried out in a 10 μL final volume, 90 containing 0.5 ng of DNA and 1X Master Mix (Cy5 ® , HEX TM and FAM TM labeled probes; 91 ROX TM as passive reference; specific forward and reverse primers) (Neoprospecta 92 Microbiome Technologies, Brazil) . A negative reaction control and a positive control of each 93 resistance gene (characterized strains containing the gene of interest) were included and the 94 assays were carried out in triplicate. The ICU-B also showed the highest prevalence of HAI-related GNB resistant to carbapenems, 138 44.6% (statistically different from the other units), followed by IMW with 20.7%, ICU-A 139 with 16.4%, SUW with 7.7% and EMG with 6.8% (p<0.0001). Resistance to carbapenems 140 was not detected in GNB isolated from GSU. Once again, resistance to extended-spectrum 141 cephalosporins was higher in ICU-B with 60.7% and in IMW with 44.8%, followed by ICU-142 A with 36.4%, EMG with 31.5%, SUW with 26.9% and GSU with 18.8% (p=0.0014) ( Figure  143 3, Table S4 ). 144
We separated the collected samples into groups (representing the areas of the hospital or the 145 isolation sites) with the distribution of GNB and their resistance profile ( Figure 4 , Table S5 ). 146
Analysis of this data allowed us to identify the critical points of contamination within the 147 studied areas. 148
Characterization of the patient-related samples 149
During the sampling period, a total of 66 patients had their samples collected, including 150 7 samples from their respective beds (HE samples) in all hospital units, except GSU. The 151 average age of the patients was 63.2 years, being 47.0% female and 53.0% male. The average 152 length of hospital stay was 15.3 days and, unexpectedly, the longer hospitalization was seen 153 for SUW patients, with 24.3 days, followed by IMW (23.4 days), ICU-B (15.0 days), ICU-A 154 (10.4 days) and EMG (6.8 days). More than half of these patients (54.5%) were admitted to 155 more than one unit of the hospital and 65.2% undergone at least one invasive procedure. 156
Medical records also show that 50.0% of the patients did not present HAI during the current 157 hospitalization, 43.9% had a HAI during the current hospitalization and 6.1% were colonized 158 by HAI-related bacteria. The results of the present study showed that 62 patients (93.9%) had 159 at least one HAI-related GNB isolated from their samples and 63.6% of the patients had at 160 least one MDR GNB, 39.4% had an extended-spectrum cephalosporin GNB and 28.8% had a 161 carbapenem resistant GNB. From the patients with two or more sites colonized by HAI-162 related GNB ( Enterobacter cloaceae and Escherichia coli) in PT, HE and HCW are presented in Tables S6,  174 S7 and S8. Analysis of the antimicrobial resistance profiles did not show statistically 175 8 significant differences among the different GNB sources (PT, HE and HCW) ( Figure 5A ). 176 MDR profile was found in 35.0% of the Enterobacteriaceae, carbapenem resistance was 177 present in 14.5% and extended-spectrum cephalosporins resistance was found in 30.9%. In 178 PT, HE and HCW, MDR was found in 40.3% (50/124), 29.4% (25/85) and 18.2% (2/11) of 179 the Enterobacteriaceae isolates, carbapenem resistance was identified in 17.7%, 9.4% and 180 18.2% and extended-spectrum cephalosporins resistance was present in 31.4%, 29.4% and 181 36.4%, respectively, with no statistically significant differences among the groups tested. 182
When the three most frequent species of Enterobacteriaceae were analyzed separately, in 183 patients (PT) we found that MDR, carbapenem resistance and extended-spectrum 184 cephalosporins resistance for these species were, respectively, 66.7%, 45.8% and 62.5% for 185
Klebsiella pneumoniae (n=24), 65.0%, 40.0% and 65.0% for Enterobacter cloacae complex 186 (n=20) and 32.1%, 1.9% and 17.0% for Escherichia coli (n=53). For hospital environment 187 (HE) samples, K. pneumoniae (n=29) and E. cloacae complex (n=25) were classified as 188 MDR in 41.4% and 28.0% of the cases, respectively, 13.8% and 12.0% were carbapenem 189 resistant and 48.3% and 32.0% presented resistance to extended-spectrum cephalosporins. 190
We found a case of a IMW patient colonized by MDR (carbapenem and extended-spectrum 191 cephalosporins resistant) K. pneumoniae in the three isolations sites (rectal swab, hands and 192 nasal). In healthcare workers (HCW) we found two K. pneumoniae, three E. cloacae complex 193 and one E. coli, being the two E. cloacae complex isolates MDR and resistant to 194 carbapenems. 195
Frequencies of resistance genes detected by qPCR in HAI-related Enterobacteriaceae from 196
PT, HE and HCW are presented in Figure 6 as a heat map, emphasizing the most important 197 GNB of the family (K. pneumoniae, E. cloacae complex and E. coli) (Table S9 shows  198 resistance genes frequencies with the respective Cq mean). The bla KPC-like gene was found in 199 5.9% (13/220) of Enterobacteriaceae, all of them resistant to carbapenems and identified as 200 9 K. pneumoniae, E. cloacae complex or Escherichia coli. In another Enterobacteriaceae 201 species resistant to carbapenems we did not found bla KPC-like or any other tested 202 carbapenemase encoding gene. Klebsiella pneumoniae recovered from PT (n=24) presented 203 concern beta-lactamase genes frequencies: 91.7% for bla SHV-like , 37.5% for bla CTX-M-1 group, 204 33.3% for bla KPC-like , 25.0% for bla CTX-M-9 group and 16.7% for bla CTX-M-8 group (some of 205 these K. pneumoniae harboring three or more beta-lactamase genes). 206
Acinetobacter spp. antimicrobial resistance profile 207
Using the phenotypic identification, we found that 92.5% (49/53) were Acinetobacter 208 baumannii complex, 5.7% (3/53) were Acinetobacter lwoffii and 1.9% (1/53) Acinetobacter 209
radioresistens. 210 Table S10 shows the phenotypic antimicrobial resistance profile of 52 HAI-related 211
Acinetobacter spp. in PT, HE and HCW (Table S11 shows AST results for Acinetobacter 212 baumannii complex separately). For Acinetobacter spp. the highest resistance to 213 antimicrobials was seen in PT ( Figure 5B ): 92.3% (12/13) were MDR and resistant to 214 carpapenems (imipenem or meropenem). The bla OXA-23-like gene, which confers resistance to 215 carbapenems, was identified at the same frequency (92.3%) ( Figure 6 ). In HE and HCW 216 carbapenem resistance were lower, 18.2% (6/33) and 16.7% (1/6) respectively. When PT, HE 217 and HCW were analyzed together Acinetobacter spp. still showed the highest carbapenem 218 resistance of all HAI-related GNB: 36.5%. MDR profile was found in 34.6% of 219 Acinetobacter spp.: 92.3% (12/13) in PT, 15.2% (5/33) in HE and 16.7% (1/6) in HCW. The 220 carbapenems resistance and MDR profiles were statistically significant different when we 221 compare PT with HE or HCW (p<0.0001). Extended-spectrum cephalosporins resistance 222 (cefepine, ceftazidime or ceftriaxone) was found in 100%, 90.9% and 100% of PT, HE and 223 HCW respectively ( Figure 5B ). 224 Figure 6 shows the frequencies of beta-lactamase genes detected by qPCR in HAI-related 225 10 Acinetobacter spp. from PT, HE and HCW, with A. baumannii complex analyzed separately 226 (Table S9 ). In A. baumannii complex (n=49) the bla OXA-23-like was found in 40.8% of the 227 isolates and, interestingly, bla OXA-51-like (intrinsic in A. baumannii) was found only in 53. Table S12 239 (Table S13 shows There is a high risk of acquiring HAI in developing countries, reaching up to 27%. The fight 253 to improve patient safety is difficult because of the increasing antimicrobial resistance rates, 254 coupled to other serious health systems problems and to the fact that health authorities are not 255 sufficiently prepared to face the problem (18-19). Gram-negative bacteria (GNB) present a 256 good performance against the antibiotics, making them a leading cause of HAI and a matter 257 of great concern for the currently available therapies (20) . We found that 32.6% of the HAI-related GNB were MDR and no statistically significant 283 differences were seen for PT (47.7%), HE (29.1%) and HCW (26.3%). Brazilian studies 284 found MDR profile for GNB isolated from patients ranging from 32% to 48% (29, 30) . 285
In the present study, the resistance rate to carbapenems was 17.7%, being 24.2% when 286 considering only the PT samples. The average carbapenem resistance reported in the 287 literature for HAI diagnosed patients samples is 42.7% (31-37). The extended-spectrum 288 cephalosporins resitance were identified in 38.7% of the total GNB (35.0% for PT). 289
Additionally, the average extended-spectrum cephalosporins resistance or ESBL profile 290 reported from the literature for patient-related samples was 31.7% (21, 32, 38-40). 291
The results presented for hospital environment and equipment showed that the rest areas of 292 the healthcare workers, like the lunch and the sleeping rooms, were highly contaminated, also 293 including positive results for MDR bacteria. The number of isolated GNB found in these 294 areas were only smaller than those from the rectal swabs. Common work areas and hospital 295 medical equipment were also critical points of contamination, many many harbouring 296 carbapenems-resistant GNB. We identified five cases of healthcare workers contamination 297 with MDR GNB (four from hands e one from protective clothes), three of them resistant to 298 carbapenems. 299 13 The only hospital unit that showed statistically different frequencies of HAI-related GNB was 300 GSU, with a low frequency of GNB. This result could be due to the fact that no patient 301 samples were collected in this unit and also because one of the surgical rooms was always 302 collected after its disinfection. Among the other hospital units we saw similar GNB rates, 303 indicating a systematic contamination in the hospital. Additionally, PT, HE and HCW 304 isolates did not show significant differences in the resistance profile, which suggests a 305 homogeneous spread of resistant GNB through the hospital. to previous studies (32, 33). The AST for K. pneumoniae isolated from environment and 322 healthcare workers was very similar to the AST identified for Klebsiella spp. isolated from 323 patients in previous studies (32, 34). However, when we compare the AST results of K. 324 14 pneumoniae isolated from patients in the present study we found higher resistance rates than 325 previous reports (32, 34). For E. cloacae complex we found a similar scenario: in the present 326 study the isolates from patients had higher resistance rates than reported in literature (32, 34) . 327
It is important to emphasize that the study presented here includes GNB isolated from 328 patients with infection or colonization, as well as from the environment and healthcare 329 workers, which further draws attention to the higher resistance rates that were found. 330
The bla SHV-like shows the highest frequencies of all resistance genes tested, reaching up 91.7% 331 for K. pneumoniae isolated from patients, and the frequencies found (in Enterobacteriaceae or 332 specific species) are in accordance with previous studies (41, 42, 43). The bla CTX-M-1 , bla CTX-333 M-8 and bla CTX-M-9 groups were the most frequents of the CTX-M family genes. These findings 334 were similar to several studies (42, 44). The bla CTX-M-2 was identified with lower frequencies 335 and only in E. coli, as previously reported (38, 45). However, other studies reported higher 336 bla CTX-M-2 frequencies in Enterobacteriaceae, with results ranging between 52.3% and 89.3% 337 (41, 42, 46) . For the bla KPC-like we found a 6.4% frequency for Enterobacteriaceae and 33.3% 338 for K. pneumoniae isolated from patients, in accordance with previous studies (38, 47-50). 339
In Acinetobacter spp. we found an antimicrobial profile significantly more resistant in 340 patients than in hospital settings and healthcare workers. 341
The bla OXA-23-like detection in A. baumannii complex isolated from patients followed the rate 342 of carbapenem resistance, actually they were the same (92.3%), which shows the importance 343 of this carbapenemase gene for this species. The carbapenem resistance studies with 344 Acinetobacter spp. isolated from patients ranged between 30.0% and 91.2% (30, 31, 34-36), 345 while bla OXA-23-like frequencies are reported from 41.7% to 100% (51, 52). The absence of 346 bla OXA-51-like in some A. baumannii complex isolates, that includes A. baumannii, A. resistance rate for all the tested antibiotics. However, in both studies we see higher 358 carbapenems resistance rates, that ranged from 38.4% to 46.7%. In the present study we 359 identified the resistance to meropenem was found in 21.1% and to imipenem in 26.3% of the 360 P. aeruginosa isolated from patients. 361
In P. aeruginosa, we highlight the presence of bla SPM-like gene (15.8% for isolates from 362 patients) which highly accounted to define the phenotypic MDR profile. Previous studies 363 with P. aeruginosa reported bla SPM-like frequencies close to 6.0% (33, 36), while studies with 364 P. aeruginosa with a MDR or carbapenem resistant profile reported higher and more variable 365 frequencies, ranging from 17.8% to 64.1% (59, 60). 366
Despite the report of several cases of bla NDM-like in Brazil in different GNB species (31, 61), 367 the present study did not identify this carbapenemase gene, which can be explained by its low 368 incidence in the country, 0.97% in Enterobacteriaceae according to Rozales et al. (62) . The 369 bla IMP-like and bla VIM-like metalo-beta-lactamases (MBL) genes and bla GES-like carbapenemase 370 gene were also not found in the present surveillance program, however others Brazilian 371 studies found low frequencies of these genes in P. aeruginosa and A. baumannii (33, 36, 43, 372 59) . 373
It is important to point out that all studies cited were carried out with GNB isolated from 374 16 patients and the identification of the resistance genes were restricted in most of the cases to 375 resistant GNB (ESBL, MBL or carbapenem resistant, for example), becoming an important 376 bias for the comparative analysis. 377
There were two interesting cases of patients showing contaminated by GNB in the three 378 isolation sites (hands, nasal and rectal swabs). One of them was a case involving P. 379 aeruginosa that occurred to an ICU patient and the other was a IMW patient, colonized by K. 
